BridgeMD
New treatment option for Type 2 Diabetes Mellitus
Official title Antidiabetic Effect of Olive Pomace Oil
ClinicalTrials.gov ID: NCT06723886
What this study is testing
- What it's testing
- This clinical trial aims at assessing whether consumption of olive pomace oil in the diet may benefit persons with type 2 diabetes mellitus or persons at risk of developing the disease (prediabetic persons). The main questions the study aims to answer are: May olive pomace oil prevent a high increase of blood glucose levels when consumed in a meal together with carbohydrates in diabetic/prediabetic patients?
- Time commitment: about 22 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 70
You may be able to join if
- Fasting blood glucose between 100-126 mg/dL and/or
- Glycated haemoglobin (HbA1c) between 5.7-6.4% and/or
- Diabetic persons with Fasting blood glucose \>126 mg/dL and/or
- Diabetic persons with Glycated haemoglobin (HbA1c) \> 6.4%
You likely can't join if
- Kidney or liver diseases
- Gastrointestinal diseases (irritable bowel syndrome, Crohn disease, chronic bowel inflammation)
- Food allergies/intolerances
- Vegetarians/vegans
- Smoking
- Pregnant or lactating women
See the full eligibility criteria
- Fasting blood glucose between 100-126 mg/dL and/or
- Glycated haemoglobin (HbA1c) between 5.7-6.4% and/or
- Diabetic persons with Fasting blood glucose \>126 mg/dL and/or
- Diabetic persons with Glycated haemoglobin (HbA1c) \> 6.4%
- Kidney or liver diseases
- Gastrointestinal diseases (irritable bowel syndrome, Crohn disease, chronic bowel inflammation)
- Food allergies/intolerances
- Vegetarians/vegans
- Smoking
- Pregnant or lactating women
- On prescription drugs other than for hypertension/thyroid/dyslipidemia/glucose control, or changes in dosage in the last 3 months
- Consumption of vitamins, dietary supplements or nutraceuticals
The study team makes the final eligibility decision.
Where it's taking place
- Madrid, Madrid, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 22 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Madrid, Madrid, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.